Literature DB >> 30642828

The role of high-flow nasal cannula therapy in patients with respiratory failure.

Xuping Cheng1, Weimin Zhang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30642828      PMCID： PMC6333541          DOI： 10.1503/cmaj.71024

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  Failure of high-flow nasal cannula therapy may delay intubation and increase mortality.

Authors:  Byung Ju Kang; Younsuck Koh; Chae-Man Lim; Jin Won Huh; Seunghee Baek; Myongja Han; Hyun-Suk Seo; Hee Jung Suh; Ga Jin Seo; Eun Young Kim; Sang-Bum Hong
Journal:  Intensive Care Med       Date:  2015-02-18       Impact factor: 17.440

2.  Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: a meta-analysis of randomized controlled trials.

Authors:  Xiaofeng Ou; Yusi Hua; Jin Liu; Cansheng Gong; Wenling Zhao
Journal:  CMAJ       Date:  2017-02-21       Impact factor: 8.262

3.  Use of High-Flow Nasal Cannula for Acute Dyspnea and Hypoxemia in the Emergency Department.

Authors:  Nuttapol Rittayamai; Jamsak Tscheikuna; Nattakarn Praphruetkit; Sunthorn Kijpinyochai
Journal:  Respir Care       Date:  2015-06-09       Impact factor: 2.258

4.  Direct extubation onto high-flow nasal cannulae post-cardiac surgery versus standard treatment in patients with a BMI ≥30: a randomised controlled trial.

Authors:  Amanda Corley; Taressa Bull; Amy J Spooner; Adrian G Barnett; John F Fraser
Journal:  Intensive Care Med       Date:  2015-04-08       Impact factor: 17.440

5.  Randomized Controlled Trial of Humidified High-Flow Nasal Oxygen for Acute Respiratory Distress in the Emergency Department: The HOT-ER Study.

Authors:  Peter G Jones; Sinan Kamona; Owen Doran; Frann Sawtell; Margaret Wilsher
Journal:  Respir Care       Date:  2015-11-17       Impact factor: 2.258

6.  Effect of Postextubation High-Flow Nasal Cannula vs Conventional Oxygen Therapy on Reintubation in Low-Risk Patients: A Randomized Clinical Trial.

Authors:  Gonzalo Hernández; Concepción Vaquero; Paloma González; Carles Subira; Fernando Frutos-Vivar; Gemma Rialp; Cesar Laborda; Laura Colinas; Rafael Cuena; Rafael Fernández
Journal:  JAMA       Date:  2016-04-05       Impact factor: 56.272

7.  Randomised control trial of humidified high flow nasal cannulae versus standard oxygen in the emergency department.

Authors:  Nerida Bell; Claire L Hutchinson; Timothy C Green; Eileen Rogan; Kendall J Bein; Michael M Dinh
Journal:  Emerg Med Australas       Date:  2015-09-29       Impact factor: 2.151

8.  Nasal high-flow versus Venturi mask oxygen therapy after extubation. Effects on oxygenation, comfort, and clinical outcome.

Authors:  Salvatore Maurizio Maggiore; Francesco Antonio Idone; Rosanna Vaschetto; Rossano Festa; Andrea Cataldo; Federica Antonicelli; Luca Montini; Andrea De Gaetano; Paolo Navalesi; Massimo Antonelli
Journal:  Am J Respir Crit Care Med       Date:  2014-08-01       Impact factor: 21.405

9.  Open-label, phase II study of routine high-flow nasal oxygen therapy in cardiac surgical patients.

Authors:  R Parke; S McGuinness; R Dixon; A Jull
Journal:  Br J Anaesth       Date:  2013-08-06       Impact factor: 9.166

10.  The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial.

Authors:  Virginie Lemiale; Djamel Mokart; Julien Mayaux; Jérôme Lambert; Antoine Rabbat; Alexandre Demoule; Elie Azoulay
Journal:  Crit Care       Date:  2015-11-02       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.